OP01-1 A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19 -17)

Autor: Kang, Eun Joo, Yang, Yaewon, Lee, Soohyeon, Kim, Yu Jung, Lim, Sun Min, Ahn, Myung-Ju, Lee, Youngjoo, Kim, Tae Min, Kim, Ilhwan, Ahn, Hee Kyung, Jeung, Hei Cheul, Lee, Soon Il, Oh, So Yeon, Bae, Woo Kyun, Ryu, Hyewon, Choi, Yoon Ji, Park, Kyong Hwa, Lee, Ki Hyeong
Zdroj: In ESMO Open December 2023 8(1) Supplement 6
Databáze: ScienceDirect